{"schema_version":"secwatch.filing_event.v1","accession":"0001842952-22-000098","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.663300+00:00","generated_at":"2026-06-22T01:57:18.836889+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Context Therapeutics updates corporate deck; no new material financial or clinical details.","bullets":["Corporate presentation updated as of November 2022 for investor meetings.","No specific financial results, clinical data, or strategic milestones announced.","Presentation reiterates focus on advancing medicines for female cancers."],"urls":{"canonical":"https://secwatch.observer/filing/0001842952-22-000098","json":"https://secwatch.observer/filing/0001842952-22-000098.json","markdown":"https://secwatch.observer/filing/0001842952-22-000098.md","text":"https://secwatch.observer/filing/0001842952-22-000098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000184295222000098/0001842952-22-000098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000184295222000098/cntx-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:57:18.836889+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}